Come up with a name for your new list and we'll add to it:
Arresto BioSciences was acquired by
Gilead Sciences on December 10, 2010.
Arresto Biosciences is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. Changes in the normal composition of the extracellula…